Article
Coalition of Leading Cancer Centers Aims to Improve Personalized Treatment
"The growth of ORIEN coincides with President Obama's announcement and the recognition that molecularly targeted medicine holds tremendous promise for all disease, particularly cancer," said Michael Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute.
(OSUCCC-James)
A novel research partnership anchored by two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, today announced the addition of four nationally recognized cancer centers, bringing its membership to six and extending the national oncology network from coast to coast.
The new members of the Oncology Research Information Exchange Network (ORIEN) include:
- City of Hope
- University of Virginia Cancer Center (UVA)
- University of Colorado Cancer Center
- University of New Mexico Cancer Center (UNMCC)
The addition of the new ORIEN members is expected to exponentially increase the number of patients consenting to donate their tissue and clinical data — including corresponding genomic data – for research to understand cancer at the molecular level, with the goal of developing more targeted cancer treatments.
Read the complete press release:
Source: Moffitt Cancer Center website
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
